TY  - GEN
AU  - Sperduto,Paul W
AU  - Jiang,Wen
AU  - Brown,Paul D
AU  - Braunstein,Steve
AU  - Sneed,Penny
AU  - Wattson,Daniel A
AU  - Shih,Helen A
AU  - Bangdiwala,Ananta
AU  - Shanley,Ryan
AU  - Lockney,Natalie A
AU  - Beal,Kathryn
AU  - Lou,Emil
AU  - Amatruda,Thomas
AU  - Sperduto,William A
AU  - Kirkpatrick,John P
AU  - Yeh,Norman
AU  - Gaspar,Laurie E
AU  - Molitoris,Jason K
AU  - Masucci,Laura
AU  - Roberge,David
AU  - Yu,James
AU  - Chiang,Veronica
AU  - Mehta,Minesh
TI  - The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases
SN  - 1879-355X
PY  - 2017///0814
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Brain Neoplasms
KW  - genetics
KW  - Female
KW  - Genes, ras
KW  - Humans
KW  - Immunotherapy
KW  - Linear Models
KW  - Male
KW  - Melanoma
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Mutation
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Proto-Oncogene Proteins B-raf
KW  - Proto-Oncogene Proteins c-kit
KW  - Retrospective Studies
KW  - Statistics, Nonparametric
KW  - Time Factors
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1016/j.ijrobp.2017.03.030
ER  -